Dye-cored polylysine dendrimer as luminescent nanoplatform for imaging-guided anticancer drug delivery

Colloids Surf B Biointerfaces. 2023 Feb:222:113130. doi: 10.1016/j.colsurfb.2023.113130. Epub 2023 Jan 5.

Abstract

Dendrimers have numerous applications in imaging and drug delivery. Designing a dendrimer diagnostic platform with a well-defined structure and controlled drug delivery is a formidable challenge. Here, we design dendritic polymer-platinum conjugates (G5-PEG-Pt) as pH-responsive nanovesicles for imaging-guided platinum drug delivery. The G5-PEG-Pt have a well-defined structure, intrinsically bright fluorescence, and acid-responsive drug release. The pH-responsive G5-PEG-Pt could rapidly release the platinum drug at acidic pH (5.0) than neutral pH (7.4). The G5-PEG-Pt could enter SKOV-3 human ovarian cancer cells by the endocytosis pathway and exhibited comparative cytotoxicity to free cisplatin. By virtue of the prolonged blood circulation time and the enhanced permeability and retention (EPR) effect, a 4.4-fold higher tumor platinum uptake than that of free cisplatin was achieved, potentially enhancing the therapeutic indexes of the platinum drug. Therefore, these pH-responsive platinum and fluorescent dendrimer conjugates are expected to be potent in vivo cancer optical imaging and therapy platforms.

Keywords: Dendrimer; Nanomedicine; Platinum; pH-responsive.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Cell Line, Tumor
  • Cisplatin / pharmacology
  • Dendrimers* / chemistry
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Female
  • Humans
  • Ovarian Neoplasms* / diagnostic imaging
  • Ovarian Neoplasms* / drug therapy
  • Platinum
  • Polylysine

Substances

  • Dendrimers
  • Cisplatin
  • Polylysine
  • Doxorubicin
  • Platinum
  • Antineoplastic Agents